Report Detail
Global Budesonide Market Growth 2019-2024
- RnM3035401 |
- 27 February, 2019 |
- Global |
- 164 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.
Statistic for budesonide in this report includes three product types: nasal spray, inhaler and pill&rectal forms.
North America is the largest consumer in the past years. North America occupied more than 40% consumption market share in 2015. Europe is the second largest region around the world, it occupied about 34% consumption market share in 2015.
There are three type of budesonide product in the market: nasal spray，inhaler and pill&rectal forms. Inhaler has the largest output due to the large asthma treatment market.
AstraZeneca is the leading company in the budesonide market. Its revenue from budesonide is 1.3 billion USD in 2015, occupied more than half of global budesonide market.
According to this study, over the next five years the Budesonide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Budesonide business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Budesonide market by product type, application, key manufacturers and key regions and countries.
This study considers the Budesonide value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Nasal Spray
Inhaler
Pill&Rectal Forms
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Budesonide consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Budesonide market by identifying its various subsegments.
Focuses on the key global Budesonide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Budesonide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Budesonide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Budesonide Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Budesonide Consumption 2014-2024
- 2.1.2 Budesonide Consumption CAGR by Region
- 2.2 Budesonide Segment by Type
- 2.2.1 Nasal Spray
- 2.2.2 Inhaler
- 2.2.3 Pill&Rectal Forms
- 2.3 Budesonide Consumption by Type
- 2.3.1 Global Budesonide Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Budesonide Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Budesonide Sale Price by Type (2014-2019)
- 2.4 Budesonide Segment by Application
- 2.4.1 Respiratory Disease Treatment
- 2.4.2 Nose Disease Treatment
- 2.4.3 Inflammatory Bowel Disease Treatment
- 2.5 Budesonide Consumption by Application
- 2.5.1 Global Budesonide Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Budesonide Value and Market Share by Application (2014-2019)
- 2.5.3 Global Budesonide Sale Price by Application (2014-2019)
3 Global Budesonide by Players
- 3.1 Global Budesonide Sales Market Share by Players
- 3.1.1 Global Budesonide Sales by Players (2017-2019)
- 3.1.2 Global Budesonide Sales Market Share by Players (2017-2019)
- 3.2 Global Budesonide Revenue Market Share by Players
- 3.2.1 Global Budesonide Revenue by Players (2017-2019)
- 3.2.2 Global Budesonide Revenue Market Share by Players (2017-2019)
- 3.3 Global Budesonide Sale Price by Players
- 3.4 Global Budesonide Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Budesonide Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Budesonide Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Budesonide by Regions
- 4.1 Budesonide by Regions
- 4.1.1 Global Budesonide Consumption by Regions
- 4.1.2 Global Budesonide Value by Regions
- 4.2 Americas Budesonide Consumption Growth
- 4.3 APAC Budesonide Consumption Growth
- 4.4 Europe Budesonide Consumption Growth
- 4.5 Middle East & Africa Budesonide Consumption Growth
5 Americas
- 5.1 Americas Budesonide Consumption by Countries
- 5.1.1 Americas Budesonide Consumption by Countries (2014-2019)
- 5.1.2 Americas Budesonide Value by Countries (2014-2019)
- 5.2 Americas Budesonide Consumption by Type
- 5.3 Americas Budesonide Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Budesonide Consumption by Countries
- 6.1.1 APAC Budesonide Consumption by Countries (2014-2019)
- 6.1.2 APAC Budesonide Value by Countries (2014-2019)
- 6.2 APAC Budesonide Consumption by Type
- 6.3 APAC Budesonide Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Budesonide by Countries
- 7.1.1 Europe Budesonide Consumption by Countries (2014-2019)
- 7.1.2 Europe Budesonide Value by Countries (2014-2019)
- 7.2 Europe Budesonide Consumption by Type
- 7.3 Europe Budesonide Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Budesonide by Countries
- 8.1.1 Middle East & Africa Budesonide Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Budesonide Value by Countries (2014-2019)
- 8.2 Middle East & Africa Budesonide Consumption by Type
- 8.3 Middle East & Africa Budesonide Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Budesonide Distributors
- 10.3 Budesonide Customer
11 Global Budesonide Market Forecast
- 11.1 Global Budesonide Consumption Forecast (2019-2024)
- 11.2 Global Budesonide Forecast by Regions
- 11.2.1 Global Budesonide Forecast by Regions (2019-2024)
- 11.2.2 Global Budesonide Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Budesonide Forecast by Type
- 11.8 Global Budesonide Forecast by Application
12 Key Players Analysis
- 12.1 AstraZeneca
- 12.1.1 Company Details
- 12.1.2 Budesonide Product Offered
- 12.1.3 AstraZeneca Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 AstraZeneca News
- 12.2 Cosmo Pharmaceuticals
- 12.2.1 Company Details
- 12.2.2 Budesonide Product Offered
- 12.2.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Cosmo Pharmaceuticals News
- 12.3 Teva
- 12.3.1 Company Details
- 12.3.2 Budesonide Product Offered
- 12.3.3 Teva Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Teva News
- 12.4 Mylan
- 12.4.1 Company Details
- 12.4.2 Budesonide Product Offered
- 12.4.3 Mylan Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Mylan News
- 12.5 Sandoz
- 12.5.1 Company Details
- 12.5.2 Budesonide Product Offered
- 12.5.3 Sandoz Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Sandoz News
- 12.6 Dr. Falk Pharma
- 12.6.1 Company Details
- 12.6.2 Budesonide Product Offered
- 12.6.3 Dr. Falk Pharma Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Dr. Falk Pharma News
- 12.7 Chiesi Farmaceutici S.p.A
- 12.7.1 Company Details
- 12.7.2 Budesonide Product Offered
- 12.7.3 Chiesi Farmaceutici S.p.A Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Chiesi Farmaceutici S.p.A News
- 12.8 Orion Corporation
- 12.8.1 Company Details
- 12.8.2 Budesonide Product Offered
- 12.8.3 Orion Corporation Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Orion Corporation News
- 12.9 Cipla
- 12.9.1 Company Details
- 12.9.2 Budesonide Product Offered
- 12.9.3 Cipla Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Cipla News
- 12.10 Synmosa Biopharma Corporation
- 12.10.1 Company Details
- 12.10.2 Budesonide Product Offered
- 12.10.3 Synmosa Biopharma Corporation Budesonide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Synmosa Biopharma Corporation News
- 12.11 Lunan Better Pharmaceutical
- 12.12 Shanghai Sine Promod Pharmaceutical
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Budesonide . Industry analysis & Market Report on Budesonide is a syndicated market report, published as Global Budesonide Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Budesonide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
